AML – High Risk for Relapse after Allogeneic Stem Cell Transplantation: Identifying the Patients at Risk and Considerations for Prevention
On Tuesday, February 22 at 12 PM CST, ASTCT kicked off a two-part webinar series on AML sponsored by Vor Biopharma.
Speakers and Moderator:
Moderator: Reshma Ramlal, MD, FACP; University of Kentucky Markey Cancer Center
Speaker: Muhammad Husnain, MD; University of Arizona
Stefan Ciurea, MD; University of California Irvine
Uday Popat, MD; The University of Texas, MD Anderson Cancer Center